In contrast, in various drug-treated groups (TUDCA, Syndopa, and TUDCA + Syndopa), the NF-kB expression levels were significantly reduced compared to the PD-MPTP group (P < 0.01, 0.05, and 0.001 respectively). Here, NFKB1 is linked to Parkinson disease.